{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Aurobindo%20Pharmaceutical%20Limited","name":"Aurobindo Pharmaceutical Limited","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T21:07:14.570Z"},"count":1,"matches":[{"id":"00e5230a89c3684b","posted_date":"2022-01-25","letter_issue_date":"2022-01-12","company_name":"Aurobindo Pharmaceutical Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/00e5230a89c3684b"}]}